 |
|
|
| |
STaR Study: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF
Maintains Non-Inferiority to Efavirenz/Emtricitabine/Tenofovir DF in ART-Na•ve Adults through Week 96 with a Favorable Safety Profile for Abnormal Dreams and Dizziness
|
| |
| |
Reported by Jules Levin
20th International AIDS Conference, July 20-25, 2014, Melbourne
C Cohen1, M Bloch2, D Wohl3, J Arribas4, K Henry5, J Van Lunzen6, W Towner7, E Wilkins8,
W Garner9, D Porter9, L Temme9, V Scharen-Guivel9, M Bosse9, F Rogatto9, D Piontkowsky9
1Community Research Initiative of New England, Boston, MA; 2Holdsworth House Medical Practice, Darlinghurst, NSW, Australia; 3University of North Carolina at Chapel Hill, Chapel Hill, NC, United States;
4Hospital Universitario La Paz, Madrid, Spain; 5Hennepin County Medical Center, Minneapolis, MN , United States; 6UniversitŠtsklinikum Hamburg-Eppendorf, Hamburg, Germany;
7Kaiser Permanente Medical Center, Los Angeles, CA United States; 8North Manchester General Hospital, Manchester, United Kingdom; 9Gilead Sciences, Foster City, CA United States
|
| |
|
|
|
|
|
